Protocols
When minutes matter, you want KCENTRA and optimized protocols to reduce delays in care and improve patient outcomes2,22-24
Reduce mortality2
Standardize patient care22,23
Improve resource efficiency22-24
Are your warfarin reversal protocols aligned to expert guideline recommendations?
9 guidelines recommended PCC for urgent warfarin reversal5-13
9 guidelines recommended PCC for urgent warfarin reversal5-13
Having KCENTRA on your protocol can improve patient outcomes and shorten hospital stays
Overall length of hospital stay was 43% shorter for patients treated with KCENTRA than plasma16*
Patients treated with KCENTRA had 40% lower hospital charges, on average, than patients treated with plasma16*
No increased risk of TE events and 41% risk reduction in adjusted all-cause mortality vs plasma2†
*Between January 2016 and December 2020, over 550,000 patients with a bleed were identified in the PINC AI Healthcare Database.16
†While this observational data demonstrated TE event safety, patients being treated with Vitamin K antagonist therapy have underlying disease states
that predispose them to thromboembolic events. Please note the boxed warning regarding arterial and venous thromboembolic complications.
CSL Behring Medical Information
Phone support available 24/7
Call 1-800-504-5434, select option 1
Live chat available Mon–Fri, 9 AM–5 PM ET
Email support at medinfona@cslbehring.com
Make KCENTRA part of your hospital protocol for warfarin reversal
Sign up to connect with a representative
and get more information about KCENTRA
You can also request a KCENTRA Essentials Kit that includes helpful brochures, guides, and supplies for Mix2Vial practice.
REQUEST AREPRESENTATIVE
